Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches

Activating Liver X receptors (LXRs) represents a promising therapeutic option for dyslipidemia. However, activating LXRα may cause undesired lipogenic effects. Discovery of highly LXRβ-selective agonists without LXRα activation were indispensable for dyslipidemia. In this study, in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Meimei Chen, Fafu Yang, Jie Kang, Huijuan Gan, Xuemei Yang, Xinmei Lai, Yuxing Gao
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2018-06-01
Col·lecció:	Molecules
Matèries:	LXRβ-selective agonists QSAR modeling molecular docking Kohonen
Accés en línia:	http://www.mdpi.com/1420-3049/23/6/1349
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!